Skip to main content

Want a detailed portfolio tracker?

BeiGene (ONC) P/E (2016 - 2026)

BeiGene (ONC) P/E from Feb 3, 2016 to Jun 3, 2026. The TTM BeiGene (ONC) P/E is 62.33. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BeiGene (ONC)

YearP/EChange
202662.33-48.22%
2025120.39-500.64%
2024-30.05+54.37%
2023-19.47+88.53%
2022-10.33-41.20%
2021-17.56+29.35%
2020-13.58+29.01%
2019-10.52-9.99%
2018-11.69-85.63%
2017-81.35+799.81%
2016-9.04N/A

Comparison BeiGene (ONC) P/E with competitors

BeiGene (ONC) P/E is 62.33.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.10-99.84%
ENLVEnlivex Therapeutics Ltd0.15-99.76%
FGENFibroGen Inc0.24-99.61%
TRAWTraws Pharma Inc0.47-99.24%
FBIOFortress Biotech Inc0.71-98.87%
CHRSCoherus Biosciences Inc0.98-98.43%
ORMPOramed Pharmaceuticals Inc1.47-97.64%
AGENAgenus Inc2.05-96.71%
VIVSVivoSim Labs Inc2.54-95.93%
INVAInnoviva Inc3.19-94.88%
CRMDCorMedix Inc3.65-94.15%
ABEOAbeona Therapeutics Inc4.20-93.25%
VXRTVaxart Inc4.26-93.16%
CVACCureVac N.V.4.45-92.87%
SRPTSarepta Therapeutics Inc4.62-92.58%
GLPGGalapagos NV4.86-92.21%
RIGLRigel Pharmaceuticals4.92-92.11%
ZVRAZevra Therapeutics Inc4.97-92.02%
ABUSArbutus Biopharma Corp5.69-90.87%
CGENCompugen Ltd7.38-88.15%
AUPHAurinia Pharmaceuticals Inc9.25-85.16%
ACADAcadia Pharmaceuticals Inc9.59-84.62%
PLXProtalix BioTherapeutics Inc9.91-84.10%
SPROSpero Therapeutics Inc10.73-82.78%
ADMAAdma Biologics Inc11.33-81.82%
SVASinovac Biotech Ltd11.44-81.65%
TBPHTheravance Biopharma Inc11.78-81.11%
HRMYHarmony Biosciences Holdings Inc12.18-80.46%
TGTXTG Therapeutics Inc13.18-78.86%
INCYIncyte Corp13.38-78.53%
SABSSAB Biotherapeutics Inc14.06-77.45%
XOMAXOMA Corp14.95-76.02%
REGNRegeneron Pharmaceuticals Inc14.98-75.97%
PBYIPuma Biotechnology Inc15.05-75.85%
EXELExelixis Inc15.79-74.66%
NAGENiagen Bioscience Inc16.35-73.76%
CPRXCatalyst Pharmaceuticals Inc17.34-72.17%
MDXGMimedx Group Inc17.38-72.13%
ARGXArgen X SE23.07-62.99%
HALOHalozyme Therapeutics Inc23.20-62.78%
XOMAOXOMA Corp25.34-59.34%
VRTXVertex Pharmaceuticals Inc25.66-58.84%
XOMAPXOMA Corp25.67-58.82%
CTMXCytomX Therapeutics Inc25.70-58.77%
ASNDAscendis Pharma A/S26.35-57.72%
RPRXRoyalty Pharma plc - Class A27.50-55.89%
SLNOSoleno Therapeutics Inc29.02-53.45%
LGNDLigand Pharmaceuticals Inc - Class B30.19-51.57%
BMRNBiomarin Pharmaceutical Inc37.51-39.83%
APLSApellis Pharmaceuticals Inc39.02-37.40%
KRYSKrystal Biotech Inc39.70-36.31%
GMABGenmab40.20-35.50%
TECHBio-Techne Corp68.59+10.05%
VCELVericel Corp80.63+29.35%
PHARPharming Group N.V.87.74+40.76%
ALNYAlnylam Pharmaceuticals Inc124.93+100.43%
TLXTelix Pharmaceuticals Ltd139.89+124.42%
CORTCorcept Therapeutics Inc158.39+154.10%